Risk-Adjusted Benchmarking of Long-Term Overall Survival in Patients With HER2-Positive Early-Stage Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study
Breast 2023 Aug 01;70(xx)18-24, J Thurell, N Manouchehri, I Fredriksson, U Wilking, J Bergh, L Ryden, LB Koppert, MM Karsten, NA Kiani, E HedayatiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.